CLOs on the Move

Prospect Medical Holdings

www.pmh.com

 
Prospect Medical Holdings, Inc. is a leading provider of healthcare services comprised of 22 hospitals and over 140 primary and specialty care clinics located throughout Southern California, South Central Texas, Rhode Island, New Jersey, Connecticut, and Pennsylvania. Established in 1996, Prospect Medical Holdings, Inc. has grown into a significant provider of coordinated regional healthcare services throughout Southern California, South Central Texas, Rhode Island, New Jersey, Connecticut, and Pennsylvania. We were among the first healthcare providers in the country to adopt an operating model, termed Coordinated-Regional-Care, that prefigures the objectives of the Affordable Care Act – to improve quality, reduce cost ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.pmh.com
  • 3415 South Sepulveda Boulevard 9th Floor
    Los Angeles, CA USA 90034
  • Phone: 310.943.4500

Executives

Name Title Contact Details
Laura Lacorte
Chief Compliance and Privacy Officer Profile
Leslie Prizant
Associate General Counsel Profile

Jobs

Chief Financial Officer

Prospect Medical Holdings Springfield, PA
Under the administrative direction of the Prospect Hospital Segment CFO and regional Chief Executive Officers of the East Coast facilities, the CFO will have primary accountability for generating insights and creating transparency into historical, current and forecasted financial performance, including ensuring that processes are in place to monitor and achieve ...

Similar Companies

ACRIA

ACRIA is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Talcomp

Talcomp is a Houston, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Discovery Laboratories Inc

Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.

WISH Center, The

WISH Center, The is a Downers Grove, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nexera Consulting

Nexera Consulting is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.